Processa Pharmaceuticals, Inc.

US$1.93As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PCSAHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (69.96%)
Div yield —
ROE (464.20%)
Biotechnology
Beta (5Y) 1.23
PE TTM —
TSR TTM (80.15%)
Mkt cap US$6.469M
ROIC (276.38%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.36
22.41%
(55.87%)
Hold 8|7|7|5|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
15.23%
12.07%
9.58%
10.29%
Revenue$M
0.798
0.783
0.779
0.774
7.66%
4.24%
2.43%
1.48%
Peers (US$6.469M)
Cap (US$)
PE
6.509M
—
Capital
TTM
5Y
10Y
Leveragex
2.503
(0.052)
(0.045)
EBIT/Intx
1.032
0.453
0.419
Own earn%
114.95
(56.25)
(38.59)
Sh yield%
48.62
53.59
54.16
Owners
Insiders/Inst%
13.86
50.98
Short interest%
2.72
SBC / revenue%
4.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
19–27
$1 testx
0.1
Incr. ROIC%
4